Endowment / Foundation

Updated:

Leducq Foundation

Jean and Sylviane Leducq established the Leducq Foundation in 1996, converting the wealth Jean built through Elis and RUS — two European linen-supply giants —...

Leducq Foundation logo

Leducq Foundation

Jean and Sylviane Leducq established the Leducq Foundation in 1996, converting the wealth Jean built through Elis and RUS — two European linen-supply giants — into a philanthropic vehicle for cardiovascular science. Today, the foundation is based in Boston and governed by a board led by Martin Landaluce, a longtime family associate, with Executive Director David Tancredi running operations. The foundation deploys capital through its International Networks of Excellence program, which funds transatlantic teams of basic and translational researchers. Since its launch in 2003, this program has committed over $500 million to multi-year projects connecting U.S. and European investigators. The foundation's other assets suggest a broader conventional portfolio: it has held limited-partnership interests in the Carlyle Europe Real Estate Partners III fund and the Resource Capital Fund VI, a global natural-resources vehicle. It also owns Ehlers Estate, a commercial vineyard in Napa Valley, through a separate entity. The Boston-based team remains compact. David Tancredi serves simultaneously as president of Broadview Ventures, a separate entity that runs a venture-philanthropy strategy targeting early-stage cardiovascular biotech. David Milan manages the scientific review process. The foundation's reach is binational by design: every grant-funded network must include at least one U.S. and one European principal investigator, effectively locking a transatlantic structure into every dollar it deploys. What separates Leducq from most large-research funders is its rigid structural commitment to international collaboration as a prerequisite for funding — a constraint embedded in its original mandate. It is not a discovery engine that funds individual labs; it is a network architect that forces institutions to build joint programs before they can access its capital, a posture that makes its grants function more like multilateral R&D treaties than conventional research awards.

General information

Firm type

Endowment / Foundation

Year founded

1996

Location

Region

North America

Country

United States

City

Boston

Corporate office

Boston, MA, United States

Principals

David Tancredi

Executive Director of the Leducq Foundation and President of Broadview Ventures

David Milan

Chief Scientific Officer

Martin Landaluce

President of the Board of Directors

Sector focus

Healthcare Services

Frequently asked questions

How does the Leducq Foundation select its grant recipients?

The foundation funds multi-institutional teams through its International Networks of Excellence program. Each network must include at least one U.S. and one European principal investigator, enforcing a transatlantic collaborative structure. Proposals are reviewed by the foundation's scientific advisory committee, led by Chief Scientific Officer David Milan, and grants typically span five years.

Is the Leducq Foundation a private foundation or does it operate as a venture-philanthropy vehicle?

The foundation itself is a pure grantmaking entity focused on cardiovascular research networks. However, David Tancredi, the foundation's executive director, concurrently serves as president of Broadview Ventures, a separate organization that makes venture-stage investments in cardiovascular biotech companies. The two entities are distinct in mandate and structure.

Who runs investment and grantmaking decisions at the Leducq Foundation?

Executive Director David Tancredi oversees both the foundation's operations and its grantmaking program. Scientific strategy is managed by David Milan, the chief scientific officer, while the board — led by President Martin Landaluce, a family friend of the Leducqs — governs the foundation's overall direction.

Where does the Leducq Foundation's wealth come from?

The endowment derives from the estate of Jean Leducq, the French entrepreneur who founded Elis and RUS, two large-scale European linen-supply businesses. He and his wife Sylviane established the foundation in 1996 to channel that industrial fortune into cardiovascular research.

Does the Leducq Foundation invest indirectly in other funds, or does it only make direct grants?

Beyond its primary grantmaking, the foundation has historically held limited-partnership interests in external private-equity vehicles, including Carlyle Europe Real Estate Partners III and the Resource Capital Fund VI, a fund focused on global natural resources. It also owns Ehlers Estate, a Napa Valley commercial vineyard, through a separate holding.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on endowments & foundations?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Boston Endowment / Foundation profiles